Transparency and the pharmaceutical industry
نویسندگان
چکیده
منابع مشابه
[Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
Alberto Lifshitz*, José Halabe, Luis Jasso, Alberto Frati, Carlos Alva, Óscar Arrieta, Rubén Burgos, Carlos Campillo, Miguel Ángel Celis, Manuel de la Llata, Judith Domínguez, Ricardo Islas, Mucio Moreno, Ricardo Plancarte, Alejandro Reyes, Antonio Soda, Emma Verástegui and Julio Sotelo Comité de Ética y Transparencia en la Relación Médico-Industria, Academia Nacional de Medicina de México, Mex...
متن کاملMedicine and the pharmaceutical industry.
One privilege of working in the health service today is the enormous range of effective therapies available to us. Advances in surgical techniques, tools, and materials have been more than matched by the vast number of pharmaceutical products addressing an ever wider range of conditions. Even for conditions where treatments have been available for many years, newer agents may be more potent, ha...
متن کاملThe Pharmaceutical Industry
The pharmaceutical industry raises unique economic questions because of three related features. First, the high rate of R&D, technical change and importance of patent protection raise important positive and normative questions related to industry structure, prices, profits and public policy. Second, the industry is heavily regulated in all major functions. Early regulatory requirements focused ...
متن کاملThe Pharmaceutical Distribution Industry
1. Distribute a full line of pharmaceutical products and health and beauty aids to chain stores, independent drug stores, hospitals, and other health care facilities. In other words, FoxMeyer’s customers were retailers and dispensers. 2. Provide managed care and information-based services to health care facilities, pharmacies and physicians. 3. Conduct business in franchising variety stores and...
متن کاملBiomarkers in the pharmaceutical industry.
Although biomarkers have been the essence of laboratory medicine since its inception, they are relatively new tools in the development of pharmaceutical compounds. The main utility of biomarkers for pharmaceutical companies has been in making drug development a more efficient and a cost-effective process. This is primarily the case because of the drastic and perhaps alarming increase seen in th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Royal College of Physicians of Edinburgh
سال: 2014
ISSN: 1478-2715,2042-8189
DOI: 10.4997/jrcpe.2014.402